|
Feb 19
|
Q4 2024 Halozyme Therapeutics Inc Earnings Call
|
|
Feb 14
|
Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
|
|
Feb 12
|
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
|
|
Feb 12
|
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
|
|
Feb 10
|
Is Roche Holding AG (RHHBY) The Best Annual Dividend Stock To Buy Now?
|
|
Jan 2
|
Innovent and Roche link on lung cancer therapy development
|
|
Dec 29
|
Roche has no plans for job cuts and business is healthy, CEO says
|
|
Oct 1
|
Genentech buys Regor’s CDK inhibitors in $850m deal
|
|
Oct 1
|
Roche Ramps Up Breast Cancer Pipeline With Regor's CDK Inhibitors
|
|
Sep 30
|
Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
|
|
Sep 30
|
New weight loss drugs could be developed much faster if Roche gets its way
|
|
Sep 30
|
Roche turns to a startup in search for new breast cancer drugs
|
|
Sep 27
|
J&J builds case for Talvey; FDA panel questions PD-1 drugs for certain cancers
|
|
Aug 30
|
Pharma Stock Roundup: LLY Offers Cheap Zepbound, EU Okays Some Drugs
|
|
Aug 30
|
The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
|
|
Aug 28
|
Five alternatives to Mag 7 stocks if you missed out on Nvidia
|
|
Aug 27
|
Roche Obtains Approval For its Rare Blood Disorder Drug in the EU
|
|
Aug 27
|
EC approves Roche’s monoclonal antibody PiaSky to treat PNH
|
|
Aug 27
|
Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH
|
|
Aug 26
|
J&J (JNJ) Gets EU Approval for Bladder Cancer Drug Balversa
|